November is Stomach Cancer Awareness Month, and World Pancreatic Cancer Day is today, November 21st. At Legend Biotech, we are advancing research of cell therapies to treat #PancreaticCancer and #GastricCancer. Learn more about our R&D efforts: https://lnkd.in/eNs5VmNJ #StomachCancerAwarenessMonth #PancreaticCancerAwarenessMonth #CellTherapy
About us
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
- Website
-
https://legendbiotech.com/
External link for Legend Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Somerset, New Jersey
- Type
- Public Company
- Specialties
- R&D, Cell Therapy, CAR-T, CAR-T Manufacturing, Biotechnology, and Pharmaceuticals
Locations
Employees at Legend Biotech
-
Steve Gavel
Senior Vice President, Cell Therapy Commercial Development
-
Frederik Buysse
-
Kathy Rosseel
HR Director - International HR Manager - Senior Human Resources Business Partner
-
Senthil Arumugam, MBA
Director of IT - Head of Data & AI and Application Development | Certified Databricks Azure Platform Architect | Commercial Insights | Data…
Updates
-
#LegendNews: We have earned top honors in several categories in the mid-cap biotech sector, as recognized by Extel's 2024 All-America Executive Team awards. Congrats to Ying Huang, PhD, Lori Macomber, Jessie Yeung, our board, and the whole IR team. This honor underscores our pioneering efforts in revolutionizing CAR-T #CellTherapy to cure cancer. We appreciate your support as we work to create breakthrough cancer treatments. #WeAreLegend
-
The Advanced Practitioner Society For Hematology And Oncology (APSHO)’s 2024 #JADPROLive exhibit opens today! If you’re attending, stop by our booth (#1016) to chat with our team and learn more about #CellTherapy for #MultipleMyeloma. See you there! #Oncology #Hematology #Nurses #AdvancedPractitioners
-
We recognize the challenges and gaps in care for those with small cell lung cancer (#SCLC). Our Chief Medical Officer, Mythili Koneru, shares how we remain motivated by our mission to develop cutting-edge cell therapies to support patients’ unmet needs. #LungCancer #LungCancerAwarenessMonth #CellTherapy
-
#LegendNews: Today, we released our 2024 third-quarter financial results. Our CEO, Ying Huang, shares his thoughts. Read the highlights here: https://lnkd.in/eZ97Z9Yt #CellTherapy #CART
-
Legend Biotech senior leaders and our partners at Johnson & Johnson Innovative Medicine attended the 2024 #PrixGalien USA Awards last week, where our #CellTherapy was nominated for Best Biotechnology Product. Thank you to The Galien Foundation for its ongoing commitment to scientific innovation. #WeAreLegend
-
#LegendNews: Legend Biotech will host an investor event on Sunday, December 8, at 8:00 PT during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego! Register here to access the live webcast: https://lnkd.in/e-_CB-Bf #ASH24 #Investors #CellTherapy
-
#LegendNews: Join us at the American Society of Hematology's Annual Meeting, where we will present new data on minimal residual disease (MRD) negativity rates from our Phase 3 #MultipleMyeloma study. If you’re attending, visit our exhibit booth #2805. Discover our innovative efforts in #CellTherapy and learn about our exciting oral and poster presentations! https://lnkd.in/emmMSUqJ #ASH24 #CART
-
#LegendNews: We are thrilled to announce Alan Bash as the newest member of our executive team. We welcome Alan’s commercial experience as we continue to strengthen our position in the #MultipleMyeloma treatment paradigm and drive the company’s growth of our #CellTherapy. Read more about his appointment: https://lnkd.in/eCKW6t3S
-
Our CEO, Ying Huang, spoke with BioBuzz about our plans to establish a cutting-edge research and development facility in the heart of Philadelphia’s Center City! This new space will bolster our work in #CellTherapy #Innovation, expanding our capabilities to develop next-generation therapies targeting cancers and other diseases. Anticipated to open in 2025, the facility will create 55 new jobs, adding to our already substantial U.S. presence of 1,200+ employees. Stay tuned for updates as we expand our footprint to include this dynamic city! 🔗 Read more: https://lnkd.in/emQashDJ
Similar pages
Browse jobs
Stock
LEGN
NASDAQ
20 minutes delay
$39.75
-0.39 (-0.972%)
- Open
- 40.18
- Low
- 39.09
- High
- 40.73
Data from Refinitiv
See more info on